183 related articles for article (PubMed ID: 29764446)
1. Comprehensive and integrative analysis identifies microRNA-106 as a novel non-invasive biomarker for detection of gastric cancer.
Peng Q; Shen Y; Lin K; Zou L; Shen Y; Zhu Y
J Transl Med; 2018 May; 16(1):127. PubMed ID: 29764446
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer.
Liu HN; Wu H; Tseng YJ; Chen YJ; Zhang DY; Zhu L; Dong L; Shen XZ; Liu TT
BMC Cancer; 2018 Apr; 18(1):415. PubMed ID: 29653559
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.
Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L
J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157
[TBL] [Abstract][Full Text] [Related]
4. Identification of miR-210 and combination biomarkers as useful agents in early screening non-small cell lung cancer.
Hu X; Peng Q; Zhu J; Shen Y; Lin K; Shen Y; Zhu Y
Gene; 2020 Mar; 729():144225. PubMed ID: 31830514
[TBL] [Abstract][Full Text] [Related]
5. Optimizing miRNA-module diagnostic biomarkers of gastric carcinoma via integrated network analysis.
Zhang F; Xu W; Liu J; Liu X; Huo B; Li B; Wang Z
PLoS One; 2018; 13(6):e0198445. PubMed ID: 29879180
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of MicroRNA-18a for Gastric Cancer: a Meta-Analysis.
Liang Q; Zhang G; Wang J; Sheng S
Clin Lab; 2018 Jan; 64(1):177-184. PubMed ID: 29479894
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNAs as potential biomarker for gastric cancer by system biological analysis.
Yan W; Wang S; Sun Z; Lin Y; Sun S; Chen J; Chen W
Biomed Res Int; 2014; 2014():901428. PubMed ID: 24982912
[TBL] [Abstract][Full Text] [Related]
9. Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer.
Jiang X; Jiang M; Xu M; Xu J; Li Y
Pathol Res Pract; 2019 May; 215(5):900-904. PubMed ID: 30732916
[TBL] [Abstract][Full Text] [Related]
10. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
11. A novel urinary microRNA biomarker panel for detecting gastric cancer.
Iwasaki H; Shimura T; Yamada T; Okuda Y; Natsume M; Kitagawa M; Horike SI; Kataoka H
J Gastroenterol; 2019 Dec; 54(12):1061-1069. PubMed ID: 31240436
[TBL] [Abstract][Full Text] [Related]
12. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
13. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
[TBL] [Abstract][Full Text] [Related]
14. Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer.
Wang D; Fan Z; Liu F; Zuo J
Cell Physiol Biochem; 2015; 37(4):1454-62. PubMed ID: 26509997
[TBL] [Abstract][Full Text] [Related]
15. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.
Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z
PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis.
Ren J; Kuang TH; Chen J; Yang JW; Liu YX
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):120-130. PubMed ID: 28121346
[TBL] [Abstract][Full Text] [Related]
17. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y
Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652
[TBL] [Abstract][Full Text] [Related]
18. Identification of microRNA-92a and the related combination biomarkers as promising substrates in predicting risk, recurrence and poor survival of colorectal cancer.
Peng Q; Shen Y; Lin K; Zou L; Shen Y; Zhu Y
J Cancer; 2019; 10(14):3154-3171. PubMed ID: 31289586
[No Abstract] [Full Text] [Related]
19. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
[TBL] [Abstract][Full Text] [Related]
20. Potential Targets and Clinical Value of MiR-224-5p in Cancers of the Digestive Tract.
Zhang L; Huang LS; Chen G; Feng ZB
Cell Physiol Biochem; 2017; 44(2):682-700. PubMed ID: 29169158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
